Related Experiment Video
Updated: May 30, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
The use of microarray technologies in mantle cell lymphoma.
Boris A Ratsch1, Michael Grau, Bernd Dörken
1Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Seminars in Hematology
|July 26, 2011
Summary
Gene expression profiling using DNA microarrays advances understanding of mantle cell lymphoma (MCL) pathogenesis. This technology aids in predicting treatment response and personalizing patient risk profiles for improved outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Mantle cell lymphoma (MCL) presents an adverse prognosis, necessitating novel therapeutic strategies.
- Understanding MCL's molecular pathogenesis is crucial for developing effective treatments.
Purpose of the Study:
- To review the application of microarray technology in mantle cell lymphoma research.
- To highlight the role of gene expression profiling in understanding MCL.
Main Methods:
- Gene expression profiling using DNA microarrays.
- Review of current literature on microarray technology in MCL.
Main Results:
- Microarray technology has significantly enhanced the understanding of MCL molecular pathogenesis.
- Gene expression profiling aids in predicting treatment response and patient risk stratification.
Conclusions:
- Microarray-based gene expression profiling is a valuable tool for advancing MCL research and clinical practice.
- This technology supports the development of personalized treatment strategies for MCL patients.
